Hemagglutinin (HA) Overview
Molecule Name
Influenza virus hemagglutinin glycoproteins
Synonyms
HA,Hemagglutinin
Drug Development Progress
Drugs in Clinical Trials3
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Hemagglutinin，HA，Hemagglutinin Glycoproteins， Influenza Virus
Hemagglutinin (HA) Product List
Species
- Influenza (A/Wisconsin/67/2022)（1）
| Cat. No. | Product Name | Size&Price |
|---|---|---|
Mouse Anti-Influenza (A/Wisconsin/67/2022) Antibody IgG Titer ELISA Assay Kit (HA) | $670.00 96tests |
You Have Viewed 1-1 Of 1 Results
FAQ
How should the HA titer kit be stored?
Store the unopened kit at 2–8°C. After opening, the stated shelf life is 30 days, with component-specific storage requirements.
How should a vaccine study use this endpoint?
Treat the result as an HA-specific IgG-titer readout; it does not alone measure neutralizing activity.
What ELISA format does the HA titer kit use?
It uses indirect ELISA. Follow the kit instructions for plate setup, sample dilution, and titer calculation.
Which species and strain are specified?
The product is specific to mouse serum and influenza A/Wisconsin/67/2022; do not assume cross-strain compatibility.
Does this kit measure HA antigen concentration?
No. The listed kit measures mouse anti-HA IgG titer, rather than the concentration of HA protein.
What research use is stated for the kit?
It is presented for evaluating immunogenicity during preclinical influenza vaccine development.
What sample type does RAS-T226 use?
The kit is designed for mouse serum. Follow its dilution and handling instructions.
Which kit supports HA-specific IgG measurement in mouse studies?
RAS-T226 measures mouse IgG against influenza A/Wisconsin/67/2022 hemagglutinin (HA).
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Anti-influenza monoclonal antibody (AIMM Therapeutics) | Phase 1 Clinical | Aimm Therapeutics | Influenza, Human | Details | |
| cH8/1N1 LAIV | Phase 1 Clinical | Icahn School Of Medicine At Mount Sinai | Influenza, Human | Details | |
| Ad4-H5-Vtn (Emergent BioSolutions/National Institute of Allergy and Infectious Diseases) | Phase 1 Clinical | Emergent Biosolutions Inc | Communicable Diseases | Details |
Customer Reviews